4-iodophenyl 3-O-allyl-2-O-propionyl-β-D-glucopyranoside | 596847-23-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-iodophenyl 3-O-allyl-2-O-propionyl-β-D-glucopyranoside
• CAS: 596847-23-3
• 化学式: C₁₈H₂₃IO₇
• 分子量: 478.281
• InChiKey: VNYAHWZAZBVXJB-SOVHRIKKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.64
• 重原子数：
  26.0
• 可旋转键数：
  8.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  94.45
• 氢给体数：
  2.0
• 氢受体数：
  7.0

反应信息

• 作为反应物：
  描述：

  4-iodophenyl 3-O-allyl-2-O-propionyl-β-D-glucopyranoside 在 吡啶 、 4-二甲氨基吡啶 、 sodium azide 、 水 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 21.0h， 生成 p-iodophenyl 3-O-allyl-2-O-propionyl-6-deoxy-6-N-(m-trifluoromethyl)benzenesulfonyl-β-D-glucopyranoside
  参考文献：
  名称：

  Functionalized Glycomers as Growth Inhibitors and Inducers of Apoptosis in Human Glioblastoma Cells

  摘要：

  The effects of functionalized aryl beta-D-glycopyranosides (glycomers) on the proliferation, survival, and apoptosis of human glioblastoma cells in culture were evaluated as a way to control tumor progression. The results showed that inhibition of growth and/or induction of apoptosis can be achieved by these molecules in human glioblastoma cells. Inhibition of DNA synthesis precedes induction of apoptosis and growth inhibition. The substituents at C-1, C-2, C-3,C-4, and C-6 on the pyranosidic scaffold are important to modulate the action and the efficacy of these molecules. Human fibroblasts and brain-derived endothelial cells were less sensitive to glycomers than tumor cells. Thus, functionalized aryl beta-D-glycopyranosides represent a new class of molecules potentially able to control the progression of brain tumors.

  DOI：

  10.1021/jm0205853
• 作为产物：
  描述：

  1,2,4,6-四-O-乙酰基-3-O-烯丙基-β-D-吡喃葡萄糖 在 吡啶 、 甲醇 、 tetrafluoroboric acid 、 氢溴酸 、 sodium methylate 、 四氯化锡 、 溶剂黄146 、 三氟乙酸 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.33h， 生成 4-iodophenyl 3-O-allyl-2-O-propionyl-β-D-glucopyranoside
  参考文献：
  名称：

  Functionalized Glycomers as Growth Inhibitors and Inducers of Apoptosis in Human Glioblastoma Cells

  摘要：

  The effects of functionalized aryl beta-D-glycopyranosides (glycomers) on the proliferation, survival, and apoptosis of human glioblastoma cells in culture were evaluated as a way to control tumor progression. The results showed that inhibition of growth and/or induction of apoptosis can be achieved by these molecules in human glioblastoma cells. Inhibition of DNA synthesis precedes induction of apoptosis and growth inhibition. The substituents at C-1, C-2, C-3,C-4, and C-6 on the pyranosidic scaffold are important to modulate the action and the efficacy of these molecules. Human fibroblasts and brain-derived endothelial cells were less sensitive to glycomers than tumor cells. Thus, functionalized aryl beta-D-glycopyranosides represent a new class of molecules potentially able to control the progression of brain tumors.

  DOI：

  10.1021/jm0205853

文献信息

• Design and synthesis of functionalized glycomers as non-peptidic ligands for SH2 binding and as inhibitors of A-431 human epidermoid and HT-29 colon carcinoma cell lines
  作者：Stephen Hanessian、Oscar M. Saavedra、Fang Xie、Nadia Amboldi、Carlo Battistini

  DOI：10.1016/s0960-894x(00)00022-6

  日期：2000.3

  A set of O-subsiitutsd aryl beta-D-glucopyranosides were prepared and found to have inhibitory activity on the growth of two carcinona cell lines. (C) 2000 Elsevier Science Ltd. All rights reserved.